Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker PCG
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | Ferguson III Mark E Director | PCG PG&E Corporation | 8,676 | $114.7K | — | Nov 11, 2026 | Form 4 ↗ 1 day later · 8,675 shares | Form 144 ↗ |
| Sep 4, 2026 | Fugate William Craig Director | PCG PG&E Corporation | 6,500 | $89.4K | 10b5-1 | Sep 4, 2026 | Form 4 ↗ 5 days later · 6,500 shares | Form 144 ↗ |
| Jul 22, 2026 | Marlene Santos Officer | PCG PG&E Corporation | 158,250 | $2.8M | 10b5-1 | Jul 22, 2026 | Form 4 ↗ 2 days later · 158,250 shares | Form 144 ↗ |
| Jul 22, 2026 | Cooper Kerry Whorton Director | PCG PG&E Corporation | 1,250 | $22.5K | 10b5-1 | Jul 22, 2026 | Form 4 ↗ 2 days later · 1,250 shares | Form 144 ↗ |
| Jun 15, 2026 | Carla J. Peterman Officer | PCG PG&E Corporation | 31,786 | $530.2K | 10b5-1 | Jun 15, 2026 | Form 4 ↗ 1 day later · 31,786 shares | Form 144 ↗ |
| Jun 2, 2026 | Cooper Kerry Whorton Director | PCG PG&E Corporation | 1,250 | $20.6K | 10b5-1 | Jun 2, 2026 | Form 4 ↗ 1 day later · 1,250 shares | Form 144 ↗ |
| Apr 28, 2026 | Patricia K. Poppe Officer, Director | PCG PG&E Corporation | 31,250 | $512.3K | 10b5-1 | Apr 28, 2026 | Form 4 ↗ same day · 31,250 shares | Form 144 ↗ |
| Apr 28, 2026 | Jason M. Glickman Officer | PCG PG&E Corporation | 47,264 | $772.8K | — | Apr 28, 2026 | Form 4 ↗ same day · 47,264 shares | Form 144 ↗ |
| Mar 17, 2026 | Cooper Kerry Whorton Director | PCG PG&E Corporation | 2,500 | $46.7K | 10b5-1 | Mar 17, 2026 | Form 4 ↗ same day · 2,500 shares | Form 144 ↗ |
| Mar 16, 2026 | Carla J. Peterman Officer | PCG PG&E Corporation | 31,786 | $582.0K | 10b5-1 | Mar 16, 2026 | Form 4 ↗ same day · 31,786 shares | Form 144 ↗ |
| Mar 5, 2026 | Singh Sumeet Officer | PCG PG&E Corporation | 55,698 | $1.0M | 10b5-1 | Mar 5, 2026 | Form 4 ↗ same day · 55,698 shares | Form 144 ↗ |
| Feb 18, 2026 | John R. Simon Officer | PCG PG&E Corporation | 50,000 | $900.0K | 10b5-1 | Feb 18, 2026 | Form 4 ↗ 1 day later · 50,000 shares | Form 144 ↗ |
| Feb 18, 2026 | Patricia K. Poppe Officer, Director | PCG PG&E Corporation | 31,250 | $559.3K | 10b5-1 | Feb 18, 2026 | Form 4 ↗ same day · 31,250 shares | Form 144 ↗ |
| Oct 30, 2025 | Jason M. Glickman Officer | PCG PG&E Corporation | 29,473 | $470.0K | — | Oct 30, 2025 | Form 4 ↗ 4 days later · 29,473 shares | Form 144 ↗ |
| Aug 11, 2025 | Ferguson III Mark E Director | PCG PG&E Corporation | 7,000 | $106.0K | — | Aug 11, 2025 | Form 4 ↗ 2 days later · 7,000 shares | Form 144 ↗ |
| Apr 29, 2025 | Carla J. Peterman Officer | PCG PG&E Corporation | 32,519 | $562.5K | 10b5-1 | Apr 29, 2025 | Form 4 ↗ 2 days later · 32,519 shares | Form 144 ↗ |
| Mar 10, 2025 | Jason M. Glickman Officer | PCG PG&E Corporation | 40,239 | $632.0K | — | Mar 10, 2025 | Form 4 ↗ 1 day later · 40,239 shares | Form 144 ↗ |
| Mar 6, 2025 | Stephanie N. Williams Officer | PCG PG&E Corporation | 14,984 | $242.9K | 10b5-1 | Mar 6, 2025 | Form 4 ↗ same day · 14,984 shares | Form 144 ↗ |
| Mar 4, 2025 | Marlene Santos Officer | PCG PG&E Corporation | 125,702 | $2.1M | 10b5-1 | Mar 4, 2025 | Form 4 ↗ same day · 125,702 shares | Form 144 ↗ |
| Mar 4, 2025 | Carla J. Peterman Officer | PCG PG&E Corporation | 35,521 | $532.5K | 10b5-1 | Mar 4, 2025 | Form 4 ↗ same day · 32,521 shares | Form 144 ↗ |
| Dec 12, 2024 | Robert C. Flexon Director | PCG PG&E Corporation | 10,000 | $216.3K | — | Dec 12, 2024 | — | Form 144 ↗ |
| Dec 2, 2024 | Patricia K. Poppe Officer, Director | PCG PG&E Corporation | 55,555 | $1.1M | 10b5-1 | Dec 2, 2024 | Form 4 ↗ same day · 55,555 shares | Form 144 ↗ |
| Aug 15, 2024 | Stephanie N. Williams Officer | PCG PG&E Corporation | 38,601 | $707.1K | 10b5-1 | Aug 15, 2024 | — | Form 144 ↗ |
| Apr 30, 2024 | Patricia K. Poppe Officer, Director | PCG PG&E Corporation | 59,000 | $1.0M | 10b5-1 | Apr 30, 2024 | — | Form 144 ↗ |
| Oct 30, 2023 | Cox Julius Former Affiliate | PCG PG&E Corporation | 34,390 | $558.3K | — | Oct 30, 2023 | — | Form 144 ↗ |
| Sep 12, 2023 | Cheryl F. Campbell Director | PCG PG&E Corporation | 10,000 | $169.0K | 10b5-1 | Sep 12, 2023 | — | Form 144 ↗ |
26 items, most recent first (up to 50). Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 6:34 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances